Multi-drug resistant tuberculosis in women

Show simple item record

dc.contributor.author Stoltz, Anton Carel
dc.date.accessioned 2015-07-04T09:59:25Z
dc.date.available 2015-07-04T09:59:25Z
dc.date.issued 2015
dc.description.abstract The World Health Organisation (WHO) estimates a staggering 8.6 million new tuberculosis cases every year (Global TB report, 2013).1 Seventy five percent of the 8.6 million cases are from the Africa region. More than 500 000 of these cases are new multi-drug resistant tuberculosis (MDR TB) that has doubled from 2009 as well as 2011 and this number is currently doubling annually. Many of these cases are primary MDR TB infection or re-infection rather than previously treated tuberculosis progressing to MRD TB.2 Evidence is growing for increased transmission in congregate settings and hospitals. Currently drug susceptible tuberculosis treatment rapidly induces negative transmission compared to multi- and extreme drug resistant tuberculosis treatment that is not effective and the patient can be positive for months and still transmitting disease. en_ZA
dc.description.librarian am2015 en_ZA
dc.description.uri http://reference.sabinet.co.za/sa_epublication/medog en_ZA
dc.identifier.citation Stoltz, AC 2015, 'Multi-drug resistant tuberculosis in women', Obstetrics and Gynaecology Forum, vol. 25, no. 2, pp. 13-16. en_ZA
dc.identifier.issn 1027-9148
dc.identifier.uri http://hdl.handle.net/2263/46302
dc.language.iso en en_ZA
dc.publisher In House Publications en_ZA
dc.rights In House Publications en_ZA
dc.subject Women en_ZA
dc.subject Africa en_ZA
dc.subject Tuberculosis (TB) en_ZA
dc.subject Multi-drug resistant tuberculosis (MDR TB) en_ZA
dc.title Multi-drug resistant tuberculosis in women en_ZA
dc.type Article en_ZA


Files in this item

This item appears in the following Collection(s)

Show simple item record